Taken together, our findings showed that the use of GLP-1RAs in type 2 diabetes patients with advanced DKD resulted in a neutral cardiovascular effect, better kidney function preservation, and lower mortality
This scenario plays out constantly in Reddits r/Menopause community, where women describe losing weight on GLP-1s only to find themselves asking: is this my GLP-1, or is this menopause
Peptide or compound Primary category What researchers study Status context Semaglutide GLP-1 / metabolic Appetite, glucose, and cardiometabolic signaling FDA-approved products exist for specific indications Tirzepatide GIP/GLP-1 / metabolic Appetite, glucose, and metabolic signaling FDA-approved products exist for specific indications Retatrutide Triple agonist / metabolic GLP-1, GIP, and glucagon receptor signaling Investigational BPC-157 Tissue-repair research Gastrointestinal, tendon, and angiogenesis pathways Research-only
Utilization Management Call Center closed with on-call services available by calling 1-866-500-4571